These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 35077762)

  • 1. Exploring the dual character of metformin in Alzheimer's disease.
    Ning P; Luo A; Mu X; Xu Y; Li T
    Neuropharmacology; 2022 Apr; 207():108966. PubMed ID: 35077762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects.
    Al-Kuraishy HM; Al-Gareeb AI; Saad HM; Batiha GE
    Inflammopharmacology; 2023 Jun; 31(3):1107-1115. PubMed ID: 36849855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic insight into the role of metformin in Alzheimer's disease.
    Sanati M; Aminyavari S; Afshari AR; Sahebkar A
    Life Sci; 2022 Feb; 291():120299. PubMed ID: 34999113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
    Markowicz-Piasecka M; Sikora J; Szydłowska A; Skupień A; Mikiciuk-Olasik E; Huttunen KM
    Pharm Res; 2017 Dec; 34(12):2614-2627. PubMed ID: 28589443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
    Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
    Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings.
    Khezri MR; Yousefi K; Mahboubi N; Hodaei D; Ghasemnejad-Berenji M
    Biochem Pharmacol; 2022 Mar; 197():114945. PubMed ID: 35134385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice.
    Oliveira WH; Braga CF; Lós DB; Araújo SMR; França MR; Duarte-Silva E; Rodrigues GB; Rocha SWS; Peixoto CA
    Exp Brain Res; 2021 Sep; 239(9):2821-2839. PubMed ID: 34283253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice.
    Li J; Deng J; Sheng W; Zuo Z
    Pharmacol Biochem Behav; 2012 Jun; 101(4):564-74. PubMed ID: 22425595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model.
    Xu X; Sun Y; Cen X; Shan B; Zhao Q; Xie T; Wang Z; Hou T; Xue Y; Zhang M; Peng D; Sun Q; Yi C; Najafov A; Xia H
    Protein Cell; 2021 Oct; 12(10):769-787. PubMed ID: 34291435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes drugs in the fight against Alzheimer's disease.
    Boccardi V; Murasecco I; Mecocci P
    Ageing Res Rev; 2019 Sep; 54():100936. PubMed ID: 31330313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of Metformin in Alzheimer's disease: A translational view.
    Ríos JA; Bórquez JC; Godoy JA; Zolezzi JM; Furrianca MC; Inestrosa NC
    Ageing Res Rev; 2024 Sep; 100():102439. PubMed ID: 39074563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between Alzheimer's disease and diabetes: a focus on anti-diabetic drugs.
    Goodarzi G; Tehrani SS; Fana SE; Moradi-Sardareh H; Panahi G; Maniati M; Meshkani R
    Metab Brain Dis; 2023 Aug; 38(6):1769-1800. PubMed ID: 37335453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.
    Goozee KG; Shah TM; Sohrabi HR; Rainey-Smith SR; Brown B; Verdile G; Martins RN
    Br J Nutr; 2016 Feb; 115(3):449-65. PubMed ID: 26652155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
    J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
    Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPK: Potential Therapeutic Target for Alzheimer's Disease.
    Yang L; Jiang Y; Shi L; Zhong D; Li Y; Li J; Jin R
    Curr Protein Pept Sci; 2020; 21(1):66-77. PubMed ID: 31424367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.